Immunic, Inc. (IMUX) Net income 2016–2025
Immunic, Inc. (IMUX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$97.2MFY2025 · since FY2016: -$41.0M → -$97.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$97.2M | +3.3% |
| FY2024 | -$100.5M | -7.4% |
| FY2023 | -$93.6M | +22.3% |
| FY2022 | -$120.4M | -29.5% |
| FY2021 | -$92.9M | -111.2% |
| FY2020 | -$44.0M | -26.0% |
| FY2019 | -$34.9M | -202.7% |
| FY2018 | -$11.5M | +77.8% |
| FY2017 | -$52.1M | -27.1% |
| FY2016 | -$41.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice